Abstract-Carotid arterial diameter enlargement is a manifestation of arterial remodeling and may be a risk factor for cardiovascular disease (CVD). We evaluated the association between carotid artery diameter and risk of stroke, coronary heart disease, CVD, and all-cause mortality and explored whether the associations could be explained by processes involved in arterial remodeling, that is, blood pressure-related media thickening, arterial stiffness, arterial wall stress, and atherosclerosis. We included 4887 participants (mean age 67±9 years; 54% women) from 4 cohort studies: Rotterdam Study, NEPHROTEST, Hoorn Study, and a study by Blacher et al. Common carotid artery properties were measured using echotracking. Incident cases were recorded based on medical records. We used Cox proportional hazard models adjusting for cardiovascular risk factors and estimates of processes underlying arterial remodeling. During follow-up (mean, 11 years), 379 (8%) individuals had a stroke, 516 had a (11%) coronary heart disease, 807 had a (17%) CVD, and 1486 (30%) had died. After adjustment for cardiovascular risk factors, individuals in the highest tertile of carotid diameter (diameter >8 mm) compared with those in the lowest tertile (diameter <7 mm) had a higher incidence of stroke (hazard ratio, 1.5; 95% confidence interval, 1.1-2.0). From all estimates of processes underlying arterial remodeling, adjustment for carotid intima-media thickness attenuated this association (hazard ratio after adjustment for intima-media thickness, 1.2; 95% confidence interval, 0.9-1.6). Larger carotid diameter was associated with risk of CVD and mortality but not clearly with coronary heart disease risk. We showed that a larger carotid diameter is associated with incident stroke, CVD, and mortality. Carotid intima-media thickness, a measure of blood pressure-related media thickening, partially explained the association with stroke incidence. (Hypertension. 2018;72:85-92.
S
troke is a leading cause of death and disability worldwide. 1 The global burden of stroke has increased in the past 25 years and will continue to increase in the coming years. 1 A better understanding of stroke risk factors can aid in development of more effective preventive strategies.
Arterial remodeling, defined as the change in structural arterial properties through time in response to atherogenic or adverse hemodynamic alterations in the arterial environment, 2 is manifested by carotid diameter enlargement. Processes that may lead to carotid arterial diameter enlargement include atherosclerosis (ie, thickening of the intima), 3 blood pressure-related media thickening, 4, 5 and arterial stiffening. 6 In addition, carotid diameter enlargement may lead to an increase in circumferential wall stress. 7 A larger carotid diameter has, therefore, been hypothesized as an important predictor of stroke. 8 Some previous studies, [8] [9] [10] [11] [12] [13] [14] but not all, 15, 16 have shown that a larger carotid artery diameter is associated with a higher incidence of cardiovascular events (see Table S1 in the onlineonly Data Supplement). However, most of these studies 9, 10, 12, 14 did not investigate incident stroke as a separate outcome, and some failed to correct for important potential confounders, such as prior cardiovascular disease (CVD), 8, 9, 13 blood pressure, 9, 10 and heart rate. [8] [9] [10] [11] [12] [13] 15, 16 In addition, it is not known whether the association between carotid diameter enlargement and stroke could be explained by processes involved in arterial diameter enlargement, notably blood pressure-related media thickening, 4, 5 arterial stiffening, 6 increased wall stress, 7 and atherosclerosis. 3 These processes may act as a confounder, an antecedent, or a mediator. 17 Previous studies 11, 13, 15 that investigated the role of carotid intima-media thickness (IMT; a measure of blood pressure-related media thickening or carotid atherosclerosis) in the link between arterial diameter enlargement and risk of CVD did not find that carotid IMT affected this association. In addition, the roles of arterial stiffness and carotid wall stress (CWS) in the association between arterial diameter enlargement and risk of CVD have not been investigated.
We combined individual-level data from 4 studies to evaluate the association between carotid diameter and incident stroke. In addition, we evaluated whether this association could be explained by carotid IMT (measured adjacent to carotid plaques, and, therefore, a measure of blood pressurerelated media thickening), arterial stiffness, CWS, or carotid plaques. Finally, we evaluated the association between carotid diameter and the incidence of other outcomes than stroke, including coronary heart disease (CHD), any CVD event, and all-cause mortality.
Methods
Data are available based on the policies of the included studies, in which data are available on request subject to approval. The detailed information on the systematic review is provided in the online-only Data Supplement.
Population
We included individual-level data of all prospective cohort studies in humans (of any age) that investigated the association between carotid diameter and incident stroke, CHD events or total cardiovascular events, and all-cause mortality, and had measured carotid artery properties, together with brachial or local pulse pressure (PP), and carotid-femoral pulse wave velocity (cfPWV). Studies that had measured carotid artery properties, but not cfPWV, were not included in the present analysis. The studies included were the RS (Rotterdam Study), 18 NEPHROTEST study, 12 Hoorn Study, 6 and a study by Blacher et al 10 and comprised a total of 4887 individuals. The present study extends our individual participant data meta-analysis on the association between carotid stiffness and incident stroke and other cardiovascular events 19 that used the same eligibility criteria and included similar studies.
Rotterdam Study
RS is a prospective, population-based cohort study of determinants of several chronic diseases in individuals >55 years. In brief, the cohort started in 1990, consisting of 7983 participants aged ≥55 years living in Ommoord, a district of Rotterdam in the Netherlands (RS-I). In 2000, the first extension of the RS (RS-II) started, adding 3011 new participants who had become 55 years of age or had moved into the study district. All participants visited the research center every 3 to 4 years. 18 For this study, we included 3984 participants with available data for carotid assessment, which took place at the third visit of RS-I and the first visit of RS-II. The median follow-up duration was 10.5 years for RS-I and 9.5 years for RS-II.
NEPHROTEST Study
A prospective hospital-based cohort that started in 2000, enrolling patients who had diagnoses of stages 2 through 5 chronic kidney disease and were referred for extensive work-up by 2 nephrology departments. All patients had to be >18 years of age, not on dialysis, and without a kidney transplant. 12, 20 A subset of 168 participants with available data on carotid diameter was included in this study. The median follow-up duration was 5.5 years.
Hoorn Study
The Hoorn Study is a population-based cohort study of glucose metabolism and CVD risk among the inhabitants of the municipality of Hoorn in the Netherlands. For the present study, we used data from the 2000 Hoorn study examination. In this study, individuals were included (n=579) who had type 2 diabetes mellitus (24.6%), impaired glucose metabolism (29.5%), or normal glucose metabolism (45.8%) and in whom data on carotid diameter were available. 6, 21, 22 The median follow-up duration was 7.7 years.
Blacher
It is a prospective cohort study (n=156) that started in 1995 at the F.H. Manhès Hospital, Fleury-Mérogis, France. Patients were included who had been on hemodialysis for at least 3 months and had had no clinical CVD during the 6 months preceding entry in the study. 10 The median follow-up duration was 5.1 years.
Carotid Arterial Properties Assessment
Diameter, Distensibility Coefficient, IMT, and Wall Stress Information on the measurements per study is provided in the onlineonly Data Supplement (Table S2 ) and has been described previously. 19 In short, common carotid arterial properties were determined in plaque-free areas by ultrasound using echotracking. Echotracking is considered the gold standard measurement technique to assess carotid artery properties. 8 The carotid distensibility coefficient was calculated according to the following equation: (2∆D×D+∆D / kPa, where D is arterial diameter, ∆D is distension, and PP is brachial PP (calculated as systolic minus diastolic blood pressure). Lower carotid distensibility represents greater carotid stiffness. Carotid IMT was determined adjacent to the presence of any plaques and was calculated as the average of left and right common carotid IMT. Pulsatile and mean CWS were calculated as follows: pulsatile CWS was calculated as PP×(lumen diameter/2/IMT), kPa. In addition, mean CWS was calculated as mean arterial pressure×([lumen diameter/2]/IMT), kPa. 23 Lumen diameter was calculated as D−(2×IMT), mm.
Carotid-Femoral Pulse Wave Velocity
cfPWV was measured as previously described 8 according to recent guidelines (Table S2) . 24 
Carotid Plaques
Presence of carotid plaques was determined by ultrasound in the common, internal, and bifurcation sites of the carotid artery. Plaques were defined as a focal widening relative to adjacent segments, with protrusion into the lumen composed of either only calcified deposits or a combination of calcified and noncalcified material.
Outcome Definitions
Information on the occurrence of cardiovascular events was acquired through automated linkage with general practitioners' database or local hospital discharge forms. 12, 25, 26 Stroke events included nonfatal and fatal cerebral infarctions and intracerebral hemorrhage. CHD events included nonfatal and fatal acute myocardial infarction, coronary artery bypass grafting, and percutaneous coronary intervention. Any cardiovascular events (CVD) included stroke, CHD events, and congestive heart failure. All-cause mortality included death from any cause. Data were available on stroke, CHD and any CVD events, and all-cause mortality in the Rotterdam and Hoorn studies, on incident any CVD events and all-cause mortality in the NEPHROTEST study, and on all-cause mortality in the study of Blacher et al. 10 Further details on the outcome definitions are provided in the online-only Data Supplement (Tables S3 and S4 ).
Statistical Analyses
Missing values on covariates were imputed using the expectation maximization method (single imputation) 27 for each cohort separately. We calculated incident cardiovascular event and mortality rates according to tertiles of carotid diameter. The association between carotid diameter and outcomes was evaluated using Cox regression models.
We performed the analyses in 2 steps. First, we did a meta-analysis with results from each cohort with random effect methods. Second, we performed pooled analyses adjusting for the cohort variable. We performed the analyses in 4 models: we first adjusted the analyses for age and sex (model 1); additionally adjusted for systolic blood pressure and heart rate (model 2); additionally adjusted for other cardiovascular risk factors, including body mass index, smoking, diabetes mellitus, history of CVD, triglycerides, and total cholesterol/HDL (high-density lipoprotein) ratio (model 3); and finally additionally adjusted for use of antihypertensive and lipid-modifying medication (model 4). The proportionality assumption was met for all analyses.
We modeled carotid diameter both on a categorical (tertiles) and a continuous scale (per SD) because previous studies have reported a nonlinear association between arterial diameter and vascular events. 28 In addition, we explored the presence of nonlinear associations between carotid diameter and outcomes using restricted cubic splines with 3 knots at the 10th, 50th, and 90th percentiles, but we did not observe significant nonlinearity ( Figure S1 ).
To evaluate whether the association between carotid diameter and outcomes could be explained by blood pressure-related media thickening, arterial stiffness, wall stress, or atherosclerosis, we, additionally, adjusted the analyses for carotid IMT, cfPWV, carotid distensibility, CWS, and carotid plaques.
Furthermore, we evaluated whether associations differed according to sex, kidney function (estimated glomerular filtration rate [eGFR] <60 versus eGFR ≥60 mL/min per 1.73 meter 2 ), diabetes mellitus, and prior CVD. Finally, we repeated the analyses after excluding participants with an eGFR <60 mL/min per 1.73 meter 2 , diabetes mellitus, or prior CVD. All analyses were done using R statistical software version 3.4.2. Table 1 shows baseline characteristics of the total population and across tertiles of carotid diameter; Table 2 shows these for each cohort separately. Participants had an average age of 67±9 years, and 54% were women. Participants with a larger carotid diameter were older and had higher levels of cardiovascular risk factors compared with those with a smaller carotid diameter (Table 1) . During follow-up (mean, 10 years), 379 strokes, 516 CHD, and 807 CVD cases were identified, and 1486 individuals died. Incidence rates of stroke, CHD, any CVD, and all-cause mortality according to tertiles of carotid diameter are presented in Figure S2 . Table 3 shows pooled associations of carotid diameter (tertiles and per SD) with incident stroke and other cardiovascular outcomes and mortality; Figure S3 shows results of the individual studies. Individuals in the highest tertile of carotid diameter (diameter >8 mm) compared with those in the lowest tertile (diameter <7 mm) had a higher risk of developing stroke (hazard ratio [HR], 1.90; 95% confidence interval [CI], 1.42-2.54; Table 3 ; model 1). Adjustment for age, sex, systolic blood pressure, and heart rate did not materially change this association (Table 3 ; model 2). Additional adjustment for other cardiovascular risk factors and medication use attenuated this association, but the association Figure S4 show the association between carotid diameters and all outcomes adjusted for carotid IMT, cfPWV, carotid distensibility, pulsatile and mean CWS, and carotid plaques. From all potential factors involved in arterial remodeling, adjustment for carotid IMT most clearly attenuated the association with stroke (HR comparing those in the highest tertile to those in the lowest tertile after adjustment for IMT, 1.17; 95% CI, 0.85-1.62; corresponding to a decrease of 26%), as well as for CVD (HR comparing those in the highest tertile to those in the lowest tertile after adjustment for IMT, 1.09; 95% CI, 0.87-1.36; corresponding to a decrease of 22%). We did not observe any differences in the association between carotid diameter and any of the outcomes according to sex, an eGFR of 60 mL/min per 1.73 meter 2 , diabetes mellitus, or prior CVD (P interaction>0.05). In addition, results did not materially change after excluding individuals with an eGFR <60 mL/min per 1.73 meter 2 , diabetes mellitus, or prior CVD (Table S5) .
Results

Discussion
The present study showed that a larger carotid diameter was independently associated with a higher incidence of stroke. In addition, a larger carotid diameter was associated with incident CHD indicates coronary heart disease; CI, confidence interval; CVD, cardiovascular disease; HDL, high-density lipoprotein; NA, not applicable; and pyrs, person years. *A total of 146 participants had missing data on incident stroke, 150 on CVD, and 107 on CHD.
any CVD event, and all-cause mortality, but not clearly with incident CHD. These associations were partly explained by carotid IMT, but not by arterial stiffness, mean or pulsatile CWS, or carotid plaques. We combined data from 4 cohorts covering a population with a large risk spectrum, including apparently healthy individuals and individuals with diabetes mellitus and chronic kidney disease, to evaluate the association between carotid diameter and incident stroke. The present findings agree with and extend previous studies 8, 9, 11, 13, 15, 16 (summarized in Table  S1 ) reporting an association between larger carotid diameter and incident cardiovascular events. However, previous studies failed to correct for important potential confounders, such as prior CVD, 8, 9, 13 blood pressure, 9 and heart rate. 8, 9, 13, 15, 16 The use of individual participant data from 4 cohort studies enabled us to do a comprehensive range of additional analyses with enhanced power, including adjustments for a large number of potential confounders. Furthermore, we were able to evaluate the role of carotid IMT, stiffness, and wall stress in the association between carotid diameter and stroke.
The main finding of the present study is that larger carotid diameter was associated with a higher incidence of stroke. This relationship was attenuated after adjustment for carotid IMT but not arterial stiffness or CWS. After adjustments for all potential confounders, carotid IMT explained 26% of the association between carotid diameter and incident stroke when individuals in the highest tertile of carotid diameter were compared with those in the lowest tertile. Previous population-based studies 11, 13, 15 did not find a moderating effect of carotid IMT. However, these studies had lower statistical power when compared with the present study because they had a smaller sample size 15 or included individuals with a lower cardiovascular risk 13, 15, 16 compared with the present study. The present study included older individuals and higher risk populations with a greater variation in IMT and carotid diameter values.
The fact that the association between carotid diameter and stroke risk was attenuated by carotid IMT can be interpreted in 2 ways, which are not mutually exclusive. First, carotid diameter enlargement may reflect the compensatory remodeling of the vascular wall in response to local mean and pulsatile blood pressure (ie, thickening of the media). 4, 5 This may serve to normalize circumferential wall stress. 4, 5 In this scenario, carotid IMT confounds the association between carotid diameter and stroke, and failure to adjust for carotid IMT leads to an overestimation of this association. Second, increased carotid IMT may also be an antecedent of carotid diameter enlargement. In this scenario, adjustment for carotid IMT gives an underestimation of the association between carotid diameter and stroke. At least part of the association between carotid diameter and incident stroke remained unexplained after taking into account the carotid IMT, suggesting the possibility that carotid diameter enlargement may directly lead to stroke. An enlarged artery may be less capable to effectively control levels of endothelial shear stress. 29, 30 Arterial segments exposed to high endothelial shear stress tend to undergo vessel lumen enlargement, whereas those segments exposed to low shear stress will undergo vessel lumen narrowing. 31 This mechanism may be impaired in already enlarged arteries, 29, 30 leading to endothelial injury and a higher thrombogenicity of the arterial wall, 31 which may lead to vascular events. 28 This study does not support the hypotheses that carotid diameter is associated with stroke because of associations with arterial stiffening, increased CWS, or presence of carotid plaques as adjustment for carotid distensibility, cfPWV, CWS, or carotid plaques did not attenuate the association between carotid diameter and stroke. For CWS, we cannot exclude the possibility that this is related to a relatively large measurement error in the calculation of this estimate because it combines measurement errors of diameter, IMT, and PP, which are contained in the equation. 32 In accordance, pulsatile and mean CWS were not associated with incident stroke or any other outcome in the present study (data not shown), and no previous study has demonstrated any such association.
Carotid diameter was associated with incident stroke, incident any CVD event, and all-cause mortality, but not clearly with CHD, although the 95% CI of the effect estimate for CHD does not exclude the possibility of an association with CHD. This observation is in line with the results from the IMPROVE study (Carotid Intima Media Thickness [IMT] and IMT-Progression as Predictors of Vascular Events in a High Risk European Population). 15 Carotid atherosclerosis, which is reflected as carotid diameter enlargement, may directly lead to cerebrovascular events. In addition, carotid diameter enlargement may directly lead to stroke, but not CHD, because of local endothelial injury and a higher thrombogenicity of the carotid wall.
This study has several limitations. First, (unavoidable) survival bias may have led to an underestimation of the associations observed. Second, we were not able to make a distinction between stroke types (ie, ischemic or hemorrhagic), in part, because data on ischemic versus hemorrhagic stroke were not available in all studies. In addition, the definition of stroke differed across studies with 1 study including both ischemic and hemorrhagic and the other study only ischemic stroke. Therefore, it is unclear whether carotid diameter enlargement increases the risk of specific stroke type, and this issue needs further study. Third, we used brachial PP instead of local PP to calculate carotid stiffness and wall stress indices. This may have led to an underestimation of the explained effect by carotid stiffness and wall stress of the association between carotid diameter and stroke. However, previous studies 19, 26 suggest that calculation of carotid stiffness and wall stress using brachial PP is as accurate as using local PP in relatively older populations, such as the study populations included in the present analysis (mean age of included cohort studies ranged between 54 and 72 years). Third, we observed moderate heterogeneity between estimates from studies probably because of the differences between the included participants in each study. Adjustment for potential cardiovascular risk factors eliminated, however, a large part of the heterogeneity.
In conclusion, a larger carotid diameter is independently associated with incident stroke, and this association is explained partly by carotid IMT. This suggests that larger carotid diameter, a manifestation of arterial remodeling, is associated with incident stroke in part because it reflects blood pressure-related media thickening. A larger carotid diameter was also associated with a higher risk of any cardiovascular event and mortality but not clearly with incident CHD. Association between carotid diameter (tertiles) and risk of cardiovascular events and all-cause mortality. All associations are adjusted for age, sex, cohort, systolic blood pressure, heart rate, body mass index, smoking, diabetes mellitus, history of cardiovascular disease (CVD), antihypertensive medication, lipidmodifying medication, triglycerides, and total cholesterol/HDL (high-density lipoprotein) cholesterol ratio. In addition, results are additionally adjusted for carotid intima-media thickness (IMT), carotid-femoral pulse wave velocity (cfPWV), carotid distensibility (CD), pulsatile and mean carotid wall stress (CWS), and presence of carotid plaques. CHD indicates coronary heart disease; and HR, hazard ratio.
Perspectives
Carotid diameter enlargement is associated with a higher stroke incidence, in part because of atherosclerosis and blood pressure-related media thickening. Some part of the association between carotid diameter and incident stroke remained unexplained after taking into account the effects of carotid IMT. This suggests that larger carotid diameter, a manifestation of arterial remodeling, is associated with incident stroke, in part because it reflects blood pressure-related media thickening. Our findings emphasize the need for additional evidence to establish these associations. In particular, studies are needed to identify potential biological pathways underpinning the independent association between carotid diameter and incident stroke, to explore whether modern intensive medical therapy will improve arterial remodeling, and eventually to determine the effect of targeted preventive interventions.
